Due to its roles in such a broad array of systems, targeting the ghrelin receptor with agonists or antagonists will not only affect the phenomenon of interest, such as feeding, but will also affect the other systems in which ghrelin is involved, leading to unwanted side effects
Current studies show that after people stop taking Semaglutide, they will regain much of the weight they have lost
Wilding JP, Batterham RL, Davies M, et al
Semaglutide and its kin can slow digestion, which can boost the risk of complications with anesthesia, occasionally even causing perilous issues like pulmonary aspiration
Operating as a structural analog to native incretin hormones, this specific synthetic sequence binds directly to GLP-1 receptors to monitor insulin secretion behaviors and delayed gastric emptying profiles within test environments
Some risks include: Elevated Blood Sugar : Due to caffeines effect